DeepTek has partnered with the Greater Chennai Corporation (GCC) to provide an artificial intelligence-enabled solution for screening and triage of tuberculosis from digital chest X-rays.

DeepTek has been providing these services since 2019 and has screened over 100,000 people using its AI-first population screening platform, GENKI (a Japanese word for healthy).

DeepTek's GENKI solution reads a chest X-ray and instantly reports whether the case is a TB-suspect or not. GENKI thus helps reduce the number of patients who have to undergo molecular tests thereby reducing overall costs. Instant results also ensure that suspected patients can be educated on-the-spot and cases are not lost for follow-up.